Amanote Research
Register
Sign In
The Expression and Promoter Hypermethylation Status of MGMT, RASSF1A in Gastric Cancer
World Journal of Cancer Research
doi 10.12677/wjcr.2014.42004
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2014
Authors
昕丽 鞠
Publisher
Hans Publishers
Related search
Fibulin 1 Is Downregulated Through Promoter Hypermethylation in Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Value of P16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients With Resectable Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
MGMT Promoter Hypermethylation and K-Ras, PTEN and TP53 Mutations in Tamoxifen-Exposed and Non-Exposed Endometrial Cancer Cases
British Journal of Cancer
Cancer Research
Oncology
Downregulation of ID4 by Promoter Hypermethylation in Gastric Adenocarcinoma
Oncogene
Cancer Research
Genetics
Molecular Biology
Hypermethylation of RASSF1A in Human and Rhesus Placentas
American Journal of Pathology
Forensic Medicine
Pathology
Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status
OncoTargets and Therapy
Oncology
Pharmacology
Predictive Value of the Serum RASSF10 Promoter Methylation Status in Gastric Cancer
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Hypermethylation and Aberrant Expression of WNT Antagonist Secreted Frizzled-Related Protein 1 in Gastric Cancer
World Journal of Gastroenterology
Medicine
Gastroenterology
Aberrant Expression of the Candidate Tumor Suppressor Gene DAL-1 Due to Hypermethylation in Gastric Cancer
Scientific Reports
Multidisciplinary